Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
CJC-1295 with Drug Affinity Complex (DAC) extends its half-life, requiring only one to two injections per week for steady growth hormone (GH) and IGF-1 elevation. The No DAC version (Mod GRF 1-29) more closely mimics natural GH pulses but demands daily or multiple daily injections and stricter dosing schedules.
Key considerations include long-term safety, possible side effects, sourcing quality, and the need for ongoing medical monitoring — all of which should guide your next steps.
If you're experiencing unexplained symptoms or wondering whether hormone-related issues could be at play, don't guess. Take a free, instant, online symptom check to better understand what's going on and get clear, personalized guidance on what to do next. It only takes a few minutes and could help you move forward with confidence.
Reviewed for medical accuracy: 06/26/2026
CJC-1295 is a synthetic peptide that stimulates growth hormone (GH) release. Two main versions exist: with Drug Affinity Complex (DAC) and without DAC. Understanding their differences, potential benefits, and safety considerations is vital before using either. This guide breaks down the science, medical reality, and what to do next.
Drug Affinity Complex (DAC)
No DAC (also called Mod GRF 1-29)
| Feature | CJC-1295 DAC | CJC-1295 No DAC (Mod GRF 1-29) |
|---|---|---|
| Half-life | ~7–8 days | ~30 minutes |
| Dosing frequency | 1–2 injections/week | 1–3 injections/day |
| GH pulse pattern | Blunted, sustained GH | Mimics natural pulsatile GH |
| IGF-1 rise | More gradual, sustained | Short peaks |
| Injection convenience | High | Lower |
Pros of CJC-1295 DAC
Cons of CJC-1295 DAC
Pros of No DAC (Mod GRF 1-29)
Cons of No DAC
Limited Large-Scale Trials
Potential Benefits
Possible Risks & Side Effects
Quality Control Issues
Assess Your Goals & Risks
Talk to a Qualified Physician
Check Your Symptoms
Source from Reputable Pharmacies
Plan Your Dosing & Monitoring
Adjust and Titrate
This information is for educational purposes and does not replace medical advice. Always speak to a doctor before starting any peptide therapy, especially if you have serious or life-threatening conditions. Only a healthcare provider can evaluate your individual risks and prescribe appropriate treatment.
By understanding the differences between CJC-1295 DAC vs No DAC—and following these next steps—you can make an informed decision that prioritizes both potential benefits and safety. Your health is unique; partnering with a qualified physician and staying vigilant with monitoring will give you the best chance for a positive outcome.
(References)
* Jetté L, Léger R, Parent J, et al. hGHRH(1-29)-albumin bioconjugates activate the GHRH receptor in vitro and increase GH secretion in rats and dogs. J Clin Endocrinol Metab. 2005 Dec;90(12):6516-23. doi: 10.1210/jc.2005-0210. Epub 2005 Sep 27. PMID: 16188920.
* Svensson J, Lönn L, Jansson PA, et al. A randomized, double-blind, placebo-controlled, cross-over study with CJC-1295, a long-acting growth hormone-releasing peptide, in healthy subjects. J Clin Endocrinol Metab. 2008 Jul;93(7):2789-97. doi: 10.1210/jc.2007-1600. Epub 2008 Apr 29. PMID: 18445778.
* Svensson J, Ljunggren Ö, Isaksson O, Lönn L, Jansson PA, Frystyk J. Ghrelin, secretagogues, and a long-acting growth hormone-releasing hormone analogue (CJC-1295). J Clin Endocrinol Metab. 2010 Apr;95(4):1720-30. doi: 10.1210/jc.2009-2244. Epub 2010 Feb 24. PMID: 20181781.
* Svensson J, Ljunggren Ö. Growth hormone secretagogues: old and new. Growth Horm IGF Res. 2011 Oct;21(5):233-40. doi: 10.1016/j.ghir.2011.08.003. Epub 2011 Sep 24. PMID: 21946051.
* Frohman LA, Jansson JO, Svensson J. Growth hormone-releasing hormone (GHRH) and its analogues: therapeutic potential and current clinical applications. Rev Endocr Metab Disord. 2012 Mar;13(1):55-63. doi: 10.1007/s11154-012-9205-1. PMID: 22271383.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.